1 |
Sato S, Tanimoto A, Yanagimura N, Suzuki C, Takumi Y, Nishiyama A, Yamashita K, Takeuchi S, Ohtsubo K, Makino T, Yoshida Y, Hirono Y, Hayashi R, Koizumi T, Nakazawa Y, Ito KI, Motoo Y, Uramoto H, Nakada M, Nishino Y, Yano S. Multi-institutional survey of cancer disparities in disabled patients in the region of northwestern Japan. Int J Clin Oncol 2021;26:1009-14. [PMID: 33646436 DOI: 10.1007/s10147-021-01890-3] [Reference Citation Analysis]
|
2 |
Shin DW, Park J, Yeob KE, Yoon SJ, Jang SN, Kim SY, Park JH, Park JH, Kawachi I. Disparities in prostate cancer diagnosis, treatment, and survival among men with disabilities: Retrospective cohort study in South Korea. Disabil Health J 2021;:101125. [PMID: 34148851 DOI: 10.1016/j.dhjo.2021.101125] [Reference Citation Analysis]
|
3 |
Choi JY, Yeob KE, Hong SH, Kim SY, Jeong E, Shin DW, Park JH, Kang G, Kim HS, Park JH, Kawachi I. Disparities in the Diagnosis, Treatment, and Survival Rate of Cervical Cancer among Women with and without Disabilities. Cancer Control 2021;28:107327482110552. [DOI: 10.1177/10732748211055268] [Reference Citation Analysis]
|
4 |
Iezzoni LI. Cancer detection, diagnosis, and treatment for adults with disabilities. The Lancet Oncology 2022;23:e164-73. [DOI: 10.1016/s1470-2045(22)00018-3] [Reference Citation Analysis]
|